Cargando…
The Golgi stacking protein GRASP55 is targeted by the natural compound prodigiosin
BACKGROUND: The bacterial secondary metabolite prodigiosin has been shown to exert anticancer, antimalarial, antibacterial and immunomodulatory properties. With regard to cancer, it has been reported to affect cancer cells but not non-malignant cells, rendering prodigiosin a promising lead compound...
Autores principales: | Berning, Lena, Lenz, Thomas, Bergmann, Ann Kathrin, Poschmann, Gereon, Brass, Hannah U. C., Schlütermann, David, Friedrich, Annabelle, Mendiburo, María José, David, Céline, Akgün, Seda, Pietruszka, Jörg, Stühler, Kai, Stork, Björn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552397/ https://www.ncbi.nlm.nih.gov/pubmed/37798768 http://dx.doi.org/10.1186/s12964-023-01275-1 |
Ejemplares similares
-
Prodigiosin Sensitizes Sensitive and Resistant Urothelial Carcinoma Cells to Cisplatin Treatment
por: Berning, Lena, et al.
Publicado: (2021) -
Knockout of the Golgi stacking proteins GRASP55 and GRASP65 impairs Golgi structure and function
por: Bekier, Michael E., et al.
Publicado: (2017) -
GRASP55 and GRASP65 play complementary and essential roles in Golgi cisternal stacking
por: Xiang, Yi, et al.
Publicado: (2010) -
Fin56-induced ferroptosis is supported by autophagy-mediated GPX4 degradation and functions synergistically with mTOR inhibition to kill bladder cancer cells
por: Sun, Yadong, et al.
Publicado: (2021) -
Rapid degradation of GRASP55 and GRASP65 reveals their immediate impact on the Golgi structure
por: Zhang, Yijun, et al.
Publicado: (2020)